Science Strategic Acquisition Alpha (Science Strategic Acquisition Alpha) Sloan Ratio % : 0.00% (As of Sep. 2022)

View and export this data going back to 2021. Start your Free Trial

What is Science Strategic Acquisition Alpha Sloan Ratio %?

Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.

Science Strategic Acquisition Alpha's Sloan Ratio for the quarter that ended in Sep. 2022 was 0.00%.

Warning Sign:

When sloan ratio (100.24)% higher than 25% or lower than -25%, earnings are more likely to be made up of accruals.

As of Sep. 2022, Science Strategic Acquisition Alpha has a Sloan Ratio of 0.00%, indicating the company is in the safe zone and there is no funny business with accruals.

Science Strategic Acquisition Alpha Sloan Ratio % Historical Data

The historical data trend for Science Strategic Acquisition Alpha's Sloan Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Science Strategic Acquisition Alpha Sloan Ratio % Chart

Science Strategic Acquisition Alpha Annual Data

Trend

Dec20

Dec21

Sloan Ratio %

100.24

Science Strategic Acquisition Alpha Quarterly Data
	Oct20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
Sloan Ratio %	Get a 7-Day Free Trial			-	-	-	-	-

Competitive Comparison of Science Strategic Acquisition Alpha's Sloan Ratio %

For the Shell Companies subindustry, Science Strategic Acquisition Alpha's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Science Strategic Acquisition Alpha's Sloan Ratio % Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Science Strategic Acquisition Alpha's Sloan Ratio % distribution charts can be found below:

* The bar in red indicates where Science Strategic Acquisition Alpha's Sloan Ratio % falls into.

Science Strategic Acquisition Alpha Sloan Ratio % Calculation

Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.

Science Strategic Acquisition Alpha's Sloan Ratio for the fiscal year that ended in Dec. 2021 is calculated as

Sloan Ratio	=	(Net Income (A: Dec. 2021 )	-	Cash Flow from Operations (A: Dec. 2021 )
	-	Cash Flow from Investing (A: Dec. 2021 ))	/	Total Assets (A: Dec. 2021 )
	=	(0.159	-	-1.331
	-	-310.5)	/	311.256
	=	100.24%

Science Strategic Acquisition Alpha's Sloan Ratio for the quarter that ended in Sep. 2022 is calculated as

Sloan Ratio	=	(Net Income (TTM)	-	Cash Flow from Operations (TTM))
	-	Cash Flow from Investing (TTM))	/	Total Assets (Q: Sep. 2022 )
	=	(9.468	-	-1.044
	-	0)	/	312.401
	=	3.36%

Science Strategic Acquisition Alpha's Net Income for the trailing twelve months (TTM) ended in Sep. 2022 was 1.649 (Dec. 2021 ) + 4.75 (Mar. 2022 ) + 1.947 (Jun. 2022 ) + 1.122 (Sep. 2022 ) = $9.47 Mil.
Science Strategic Acquisition Alpha's Cash Flow from Operations for the trailing twelve months (TTM) ended in Sep. 2022 was -0.392 (Dec. 2021 ) + 0 (Mar. 2022 ) + -0.585 (Jun. 2022 ) + -0.067 (Sep. 2022 ) = $-1.04 Mil.
Science Strategic Acquisition Alpha's Cash Flow from Investing for the trailing twelve months (TTM) ended in Sep. 2022 was 0 (Dec. 2021 ) + 0 (Mar. 2022 ) + 0 (Jun. 2022 ) + 0 (Sep. 2022 ) = $0.00 Mil.

Science Strategic Acquisition Alpha (NAS:SSAAU) Sloan Ratio % Explanation

A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.

According to How to Beat the Market with the Sloan Ratio:

If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.

If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.

If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.

As of Sep. 2022, Science Strategic Acquisition Alpha has a Sloan Ratio of 0.00%, indicating the company is in the safe zone and there is no funny business with accruals.

Science Strategic Acquisition Alpha Sloan Ratio % Related Terms

Thank you for viewing the detailed overview of Science Strategic Acquisition Alpha's Sloan Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.

Science Strategic Acquisition Alpha (Science Strategic Acquisition Alpha) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Science Strategic Acquisition Corp Alpha (NAS:SSAAU) » Definitions » Sloan Ratio %

Comparable Companies

Traded in Other Exchanges

N/A

Address

1447 2nd Street, Suite 200, Santa Monica, CA, USA, 90401

Website

https://www.science-inc.com

Science Strategic Acquisition Corp Alpha is a blank check company. It is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.

Executives

Michael Gwynne Jones	director, officer: CEO	24460 MALIBU ROAD, MALIBU CA 90265
Jeff Kearl	director	C/O SKULLCANDY, INC., 1441 WEST UTE BLVD., SUITE 250, PARK CITY UT 84908
April Henry	officer: EVP, Corporate Development	C/O SCIENCE STRATEGIC ACQUISITION CORP., 1447 2ND STREET, SANTA MONICA CA 90401
Jennifer Rubio	director	C/O TISHMAN SPEYER PROPERTIES, L.P., ROCKEFELLER CENTER, 45 ROCKEFELLER PLAZA, NEW YORK NY 10111
Taylor Colette K.	director	C/O SCIENCE STRATEGIC ACQUISITION CORP., 1447 2ND STREET, SANTA MONICA CA 90401
Greg Gilman	director	C/O SCIENCE STRATEGIC ACQUISITION CORP., 1447 2ND STREET, SANTA MONICA CA 90401
Priscilla Guevara	officer: Global Head of IR	C/O SCIENCE STRATEGIC ACQUISITION CORP., 1447 2ND STREET, SANTA MONICA CA 90401
Tom Dare	officer: CFO	C/O SCIENCE STRATEGIC ACQUISITION CORP., 1447 2ND STREET, SANTA MONICA CA 90401
Peter Pham	officer: President	C/O SCIENCE STRATEGIC ACQUISITION CORP., 1447 2ND STREET, SANTA MONICA CA 90401

Science Strategic Acquisition Alpha (Science Strategic Acquisition Alpha) Headlines

No Headlines